Researcher profile · Semantic Scholar

K. Bhise

h-index: 12
Works: 25
Citations: 2,348

Most-cited papers

PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
H. Alsaab, S. Sau, R. Alzhrani, K. Tatiparti +3 more
2017Frontiers in Pharmacology1,553 citations Open access
Semantic Scholar
Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy
Jennifer M. Wickens, H. Alsaab, P. Kesharwani, K. Bhise +4 more
2016Drug Discovery Today196 citations Open access
Semantic Scholar
Multifunctional Nanoparticles for Cancer Immunotherapy: A Groundbreaking Approach for Reprogramming Malfunctioned Tumor Environment
S. Sau, H. Alsaab, K. Bhise, R. Alzhrani +2 more
2018Journal of Controlled Release136 citations Open access
Semantic Scholar
Nanostructured Lipid Carriers Employing Polyphenols as Promising Anticancer Agents: Quality by Design (QbD) approach
K. Bhise, S. Kashaw, S. Sau, A. Iyer
2017International journal of pharmaceutics92 citations Open access
Semantic Scholar
Nano-engineered delivery systems for cancer imaging and therapy: Recent advances, future direction and patent evaluation
Ghazal Nabil, K. Bhise, S. Sau, Mohamed Atef +2 more
2018Drug Discovery Today76 citations Open access
Semantic Scholar
Novel approaches for the treatment of methicillin-resistant Staphylococcus aureus: Using nanoparticles to overcome multidrug resistance
K. Vanamala, K. Tatiparti, K. Bhise, S. Sau +4 more
2020Drug Discovery Today60 citations Open access
Semantic Scholar
Nanomedicine for cancer diagnosis and therapy: advancement, success and structure-activity relationship.
K. Bhise, S. Sau, H. Alsaab, S. Kashaw +2 more
2017Therapeutic delivery54 citations
Semantic Scholar
PDL-1 Antibody Drug Conjugate for Selective Chemo-Guided Immune Modulation of Cancer
S. Sau, A. Petrovici, H. Alsaab, K. Bhise +1 more
2019Cancers53 citations Open access
Semantic Scholar
Improving the therapeutic efficiency of noncoding RNAs in cancers using targeted drug delivery systems
R. Alzhrani, H. Alsaab, A. Petrovici, K. Bhise +4 more
2019Drug Discovery Today44 citations Open access
Semantic Scholar
Combination of Vancomycin and Cefazolin Lipid Nanoparticles for Overcoming Antibiotic Resistance of MRSA
K. Bhise, S. Sau, Razieh Kebriaei, S. Rice +4 more
2018Materials24 citations Open access
Semantic Scholar
Overcoming the Tumor Microenvironmental Barriers of Pancreatic Ductal Adenocarcinomas for Achieving Better Treatment Outcomes
R. Alzhrani, H. Alsaab, Kushal Vanamal, K. Bhise +4 more
2021Advances in Therapy16 citations Open access
Semantic Scholar
Folate Functionalized Lipid Nanoparticles for Targeted Therapy of Methicillin-Resistant Staphylococcus aureus
K. Vanamala, K. Bhise, H. Sanchez, Razieh Kebriaei +6 more
2021Pharmaceutics14 citations Open access
Semantic Scholar
Leveraging hypoxia in triple-negative breast cancer as a promising treatment strategy.
K. Bhise, Navnath S. Gavande, Arun K. Iyer
2023Drug Discovery Today8 citations Open access
Semantic Scholar
Nano‐therapeutic strategies to target coronavirus
M. Rauf, M. Tasleem, K. Bhise, K. Tatiparti +2 more
2021Visual Information Expert Workshop8 citations Open access
Semantic Scholar
Development of Extraction Methods and Quantification of Safranal by High Performance Liquid Chromatography from Cuminum cyminum L . and Studying its Antimicrobial Properties
S. Kulkarni, A. Sane, K. Bhise, A. Patil +2 more
8 citations
Semantic Scholar
Imaging the cellular components of the immune system for advancing diagnosis and immunotherapy of cancers
K. Bhise, S. Sau, R. Alzhrani, M. Rauf +2 more
20214 citations Open access
Semantic Scholar
Nanomaterials for tumor immunomodulation and overcoming current clinical challenges.
S. Sau, R. Alzhrani, K. Bhise, H. Alsaab +2 more
2019Nanomedicine3 citations Open access
Semantic Scholar
Nanoparticles for Immune Cell Reprogramming and Reengineering of Tumor Microenvironment.
K. Bhise, S. Sau, R. Alzhrani, A. Iyer
2020Methods in molecular biology1 citations
Semantic Scholar
Abstract 4660: Tumor multicomponent targeting nanoparticle library for personalized cancer therapy & imaging
S. Sau, H. Alsaab, K. Tatiparti, K. Bhise +2 more
2018Cancer Chemistry1 citations
Semantic Scholar
52 Understanding cetuximab response and immune modulation in colorectal cancer using patient-derived organotypic tumor spheroids
K. Bhise, Chunxiao Cui, Kirti Khardenavis, Anthony Attardo +8 more
2023Regular and Young Investigator Award Abstracts0 citations Open access
Semantic Scholar
Inside Back Cover: Nano‐therapeutic strategies to target coronavirus (View 3/2021)
M. Rauf, M. Tasleem, K. Bhise, K. Tatiparti +2 more
2021Visual Information Expert Workshop0 citations Open access
Semantic Scholar
Considerations for Engineering Nanoparticles for Achieving Subcellular Organelle Targeting
K. Bhise, K. Tatiparti, S. Dey, K. Vanamala +3 more
2021Organelle and Molecular Targeting0 citations
Semantic Scholar
Abstract 6263: Hypoxia-targeting prodrug approach for multimodal chemotherapy and immunogenic cell death in aggressive triple negative breast cancer
K. Bhise, S. Sau, M. Rauf, A. Rishi +1 more
2020Experimental and Molecular Therapeutics0 citations
Semantic Scholar
Hypoxia Targeting Nanoparticles for Immunogenic Cell Death of Triple Negative Breast Cancer
K. Bhise, S. Sau, M. Rauf, R. Alzhrani +1 more
2020The FASEB Journal0 citations Open access
Semantic Scholar
2391. Liposomal Vancomycin and Cefazolin Combinations for S. aureus Biofilms
Razieh Kebriaei, K. Bhise, S. Sau, S. Rice +3 more
2018Open Forum Infectious Diseases0 citations Open access
Semantic Scholar

K. Tatiparti

×8

M. Rauf×5

S. Kashaw×4

K. Vanamala×4

M. Rybak×3

Razieh Kebriaei×3

R. Tekade×2

Ghazal Nabil×2